Type 1 diabetes testing could become faster, cheaper
Work by Perth researchers could revolutionise testing for type 1 diabetes around the world.
The research by the Centre for Diabetes Research (CDR) at the Western Australian Institute for Medical Research (WAIMR), led by Professor Grant Morahan, has been published in the prestigious journal Diabetes.
Lead author Cao Nguyen said the new method would make it much cheaper and quicker to determine what genetic risk factors people have for type 1 diabetes. In this disease, the person’s own immune system destroys the cells that make insulin.
The strongest genetic risk factors for type 1 diabetes are the HLA genes known as HLA-DR3 and HLA-DR4.
“Currently a blood sample is collected and sent to specialist laboratories where it can cost $300 per sample to test HLA types by the conventional method,” Research Assistant Professor Nguyen said.
“With this new method, it will cost less than $50 to find a person’s HLA risk type. The process will be more affordable and will make it easier for more researchers to investigate type 1 diabetes.”
Assistant Professor Nguyen tested more than 200,000 genetic markers in the DNA of over 10,000 people as part of the international Type 1 Diabetes Genetics Consortium.
Using advanced computational methods, Assistant Professor Nguyen discovered as few as three genetic markers can predict all the HLA risk types that are relevant to type 1 diabetes.
The overall accuracy of his prediction method was 99.3%, which is more accurate than existing methods.
Now that the research has been published, clinicians and researchers across the world can start using the method, providing faster results for people with a family history of type 1 diabetes.
A simple finger prick can be used to diagnose Alzheimer's
A new study is paving the way for a more accessible method of Alzheimer's testing, requiring...
Experimental blood test detects early-stage pancreatic cancer
The new test works by detecting two sugars — CA199.STRA and CA19-9 — that are...
Biomarkers for dementia vary with time of day
Biomarkers used to diagnose Alzheimer's, including a promising marker for early diagnosis of...